Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Effects of dry needling and electrical dry needling on latent trigger points in the forearm extensor

Official title: Effects of Dry Needling and Electrical Dry Needling on Latent Myofascial Trigger Points of the Extensor Digitorum Communis: A Randomized Clinical Trial

Run by University Rovira i Virgili · NCT07672093 · Data updated 2026-11-12

This study tests different dry needling and electrical dry needling methods to see which best reduces post-needling soreness for healthy adults with latent trigger points in the dominant forearm extensor digitorum.

More Physical Therapy trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity Rovira i Virgili
Academic / other
Locations1 site (Reus, Tarragona)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedSeptember 30, 2026
Study endsOctober 15, 2026
Registry record updatedSeptember 24, 2026
Trial IDNCT07672093 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-40 who have a latent trigger point in the extensor digitorum of the dominant forearm and no upper-limb pathology.

Probably not a fit

Individuals with needle phobia, contraindications to dry needling, or injuries affecting the treated area may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, single-blind trial, healthy adults with a latent trigger point in the extensor digitorum of the dominant forearm are assigned to five groups: a control, Hong fast-in and fast-out dry needling, rotational dry needling, bipolar electrical dry needling, or monopolar electrical dry needling. The trial compares post-needling soreness, pain during the procedure, and other functional measures such as pressure pain threshold, handgrip strength, and range of motion at several time points after intervention. Assessments occur at baseline, 5 minutes, 24, 48, and 72 hours post-treatment. The goal is to understand which technique minimizes soreness while preserving function in healthy participants.

Why it matters

Potential benefit: If successful, the findings could guide clinicians on selecting DN techniques that reduce post-treatment soreness and preserve upper-limb function.

How similar studies have gone: Previous work suggests post-needling soreness varies with technique, but evidence across these specific modalities is limited and this study explores them in healthy controls.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 40 years.
* Healthy participants with a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.
* No pathology affecting the upper limb where the intervention will be applied.
* No episode of pain in the upper limb during at least the previous two months.
* No contraindications to dry needling or electrical dry needling techniques.
* Voluntary signature of the informed consent form.
* Willingness to follow the protocol proposed by the research team.

Exclusion Criteria:

* Needle phobia.
* Coagulation disorders.
* Pregnancy.
* Thyroid disorders.
* Altered skin integrity in the treatment area.
* Epilepsy.
* Local or systemic infection.
* Diagnosed neurological disorders affecting pain perception or neuromuscular function in the region of interest, such as multiple sclerosis or peripheral neuropathies.
* Generalized chronic pain conditions, such as fibromyalgia.
* Weekly use of analgesic medication, including anti-inflammatory drugs, opioids, or other pain-relieving medication.

Where it's running

  • Facultat de Medicina i Ciències de la Salut
    Reus, Tarragona, Spain
    Recruiting

Study contacts

  • Principal investigator: Tania López Hernández — Unviersitat Rovira i Virgili
  • Study coordinator: Tania López Hernández, Phd
  • Email: tania.lopez@urv.cat
  • Phone: 34+620438175

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.